198 tracked 13F filers disclose a position in ANNX as of the latest SEC 13F filings, a combined $851.4M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | $80.6M | 14.5M | ▲+45% Added · +4.5M sh | Q1 2026 | |
| 2 | BlackRock, Inc. | $60.6M | 10.9M | ▲+22% Added · +2.0M sh | Q1 2026 | |
| 3 | FMR LLC | $58.9M | 10.6M | ▲+4.0% Added · +413K sh | Q1 2026 | |
| 4 | STATE STREET CORP | $56.1M | 9.8M | ▲+42% Added · +2.9M sh | Q2 2026 | |
| 5 | BVF INC/IL | $48.2M | 8.7M | ▼−4.7% Reduced · −430K sh | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $33.0M | 6.0M | →First observed position No prior filed position | Q1 2026 | |
| 7 | Siren, L.L.C. | $25.5M | 4.5M | ▲+13% Added · +500K sh | Q2 2026 | |
| 8 | Bain Capital Life Sciences Investors, LLC | $25.3M | 4.4M | ▼−15% Reduced · −775K sh | Q2 2026 | |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $23.8M | 4.3M | ▼−22% Reduced · −1.2M sh | Q1 2026 | |
| 10 | BANK OF AMERICA CORP /DE/ | $23.6M | 4.3M | ▲+165% Added · +2.7M sh | Q1 2026 | |
| 11 | Nuveen, LLC | $23.5M | 4.2M | ▲+46% Added · +1.3M sh | Q1 2026 | |
| 12 | Bellevue Group AG | $23.4M | 4.1M | ▼−21% Reduced · −1.1M sh | Q2 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $23.1M | 4.0M | ▲+20% Added · +659K sh | Q2 2026 | |
| 14 | BALYASNY ASSET MANAGEMENT L.P. | $21.5M | 3.9M | ▲+18% Added · +588K sh | Q1 2026 | |
| 15 | AMERIPRISE FINANCIAL INC | $19.1M | 3.4M | ▼−21% Reduced · −900K sh | Q1 2026 | |
| 16 | Qube Research & Technologies Ltd | $17.3M | 3.1M | ▲+31% Added · +733K sh | Q1 2026 | |
| 17 | Palo Alto Investors LP | $16.8M | 2.9M | —Held | Q2 2026 | |
| 18 | MORGAN STANLEY | $15.2M | 2.7M | ▼−4.2% Reduced · −120K sh | Q1 2026 | |
| 19 | GREAT POINT PARTNERS LLC | $13.8M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 20 | Woodline Partners LP | $12.9M | 2.3M | ▼−42% Reduced · −1.7M sh | Q1 2026 | |
| 21 | Opaleye Management Inc. | $12.9M | 2.3M | ▼−10% Reduced · −268K sh | Q1 2026 | |
| 22 | GOLDMAN SACHS GROUP INC | $11.9M | 2.2M | ▲+22% Added · +384K sh | Q1 2026 | |
| 23 | Point72 Asset Management, L.P. | $10.4M | 1.9M | ▲+404% Added · +1.5M sh | Q1 2026 | |
| 24 | VANGUARD PORTFOLIO MANAGEMENT LLC | $8.2M | 1.5M | →First observed position No prior filed position | Q1 2026 | |
| 25 | Tetragon Partners GP Ltd | $7.2M | 1.3M | ▼−36% Reduced · −740K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 9 funds opened a new position in ANNX and 26 added to an existing one, while 26 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 100 funds | $269.4B |
| AMAZON.COM INCAMZN | 100 funds | $127.2B |
| ELI LILLY & COLLY | 99 funds | $52.2B |
| MICROSOFT CORPMSFT | 96 funds | $177.6B |
| META PLATFORMS INC-CLASS AMETA | 95 funds | $74.6B |
| BROADCOM INCAVGO | 93 funds | $105.2B |
| ALPHABET INC-CL AGOOGL | 93 funds | $103.1B |
| MICRON TECHNOLOGY INCMU | 92 funds | $28.4B |
| ORACLE CORPORCL | 92 funds | $13.8B |
| UNITEDHEALTH GROUP INCUNH | 91 funds | $19.0B |
| BOSTON SCIENTIFIC CORPBSX | 91 funds | $10.7B |
| ADVANCED MICRO DEVICESAMD | 90 funds | $25.1B |
Ranked by how many of ANNX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| May 28, 2026 | Satter Muneer A | Director | Buy (P) | 613K | $3.3M |
| May 11, 2026 | Carson William H. | Director | Buy (P) | 8K | $46K |
| Apr 10, 2026 | Carson William H. | Director | Buy (P) | 8K | $50K |
| Mar 10, 2026 | Carson William H. | Director | Buy (P) | 8K | $45K |
| Mar 2, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell (S) | 6K | $30K |
| Mar 2, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell (S) | 6K | $32K |
| Mar 2, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell (S) | 4K | $24K |
| Mar 2, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell (S) | 6K | $30K |
| Mar 2, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell (S) | 6K | $32K |
| Feb 18, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell (S) | 8K | $40K |
| Feb 18, 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell (S) | 5K | $27K |
| Feb 18, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell (S) | 6K | $32K |
Connected entities for ANNX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ANNX/capital-change-brief"
Use Arkolith's capital_change_brief for ANNX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ANNX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.